Other techniques AG-120 molecular weight for pathogen identification such as serologic and antigen studies either alone or in combination have shown a high (about 70–88%) streptococcal predominance. These include antistreptolysin O (ASO), antideoxyribonuclease B (ADB), and antihyaluronidase (AHT) studies and immunofluorescent staining

for streptococcal antigens of groups A, C, D, and G in skin check details biopsy specimens [13, 15]. The overall body of evidence suggests that streptococci are the most common single pathogen in cellulitis [3, 12, 13, 15]. These bacteria may either cause or contribute to up to 75–90% of cases [13]. However, there are some recent reports that continue to disagree with this conclusion [9, 31]. Nevertheless, there seems to be a general agreement that cases of suppurative (or purulent) cellulitis and those associated with penetrating trauma or injection drug use are more likely to have a staphylococcal etiology [12, 15]. Yet, surgical drainage for purulent abscesses has long been the mainstay of therapy for such infections, most of which resolve without ancillary antimicrobial therapy [32]. The role of empirical therapy in these patients remains undetermined. Community-associated MRSA (CAMRSA) is probably a minor contributor to non-suppurative cases of cellulitis if at all [12, 13]. https://www.selleckchem.com/products/PLX-4032.html Gunderson and Martinello conducted

a systematic review of bacteremias in cellulitis and erysipelas, excluding reports of complicated cases, such as abscess, chronic diabetic infections and necrotizing infections [33]. Streptococcal species were the predominant culture finding, with S. aureus accounting for 15% of positive culture results. Surprisingly, Gram-negative bacteria accounted for as many cases as S. aureus. S. aureus was noted at similar rates in both erysipelas and cellulitis, at odds with the idea that almost all erysipelas is streptococcal. A recent study reported that non-suppurative cellulitis may not be significantly associated with MRSA, even in areas where CAMRSA is endemic. The authors based their

conclusions on the comparable low prevalence of nasal and inguinal colonization with CAMRSA in patients with cellulitis in comparison to population controls. The study was conducted in a region where methicillin-resistant acetylcholine strains were the dominant form of Staphylococcus aureus [18]. This finding is particularly important since most cases of cellulitis not amenable to routine culture are considered non-suppurative [8, 12]. It also reinforces the recommendation against empirical coverage for MRSA in non-suppurative cellulitis [5]. Studies of Empirical Coverage for Cellulitis At least four trials have been published since the release of the 2005 IDSA guidelines comparing beta lactams to antimicrobial agents with activity against CAMRSA in cases of outpatient cellulitis [8, 31, 34].